Form 4: Astronics Exec Plans Future Stock Acquisition
Insider Transaction Report
Mark Peabody, Executive VP & Pres-Aerospace at Astronics Corp., reported a planned future acquisition of 1,280 shares via an Employee Stock Purchase Plan.
Summary
- Mark Peabody, Executive VP & Pres-Aerospace of Astronics Corp. (ATRO), reported a planned future transaction.
- On September 30, 2025, Peabody is scheduled to acquire 1,280 shares of $.01 PV Common Stock at a price of $16.6 per share via an Employee Stock Purchase Plan (ESPP).
- Following this planned acquisition, Peabody's direct beneficial ownership will be 50,824.73 shares of $.01 PV Common Stock and 183,994 shares of $.01 PV Class B Stock.
- The filing also details existing holdings of various stock options with exercise prices ranging from $9.74 to $35.61 and expiration dates extending to December 2033.
- Peabody holds performance-based Restricted Stock Units (RSUs) with target numbers of 15,900, 10,850, and 15,150, whose vesting is contingent on Astronics Corp.'s average annual adjusted EBITDA performance for specific future periods (2023-2025, 2024-2026, and 2025-2027).
Sentiment
Score: 7
Explanation: The filing indicates an executive's planned acquisition of shares through an ESPP, which is generally a positive signal of insider confidence. The performance-based RSUs also align management incentives with company performance, contributing to a moderately positive sentiment.
Positives
- An executive's planned acquisition of shares, even through an ESPP, generally indicates confidence in the company's future prospects.
- Performance-based Restricted Stock Units align management incentives with company financial performance (adjusted EBITDA targets), fostering a focus on long-term value creation.
Negatives
- No direct negatives are present in this filing, which is a standard insider transaction report for a planned future event.
Risks
- Vesting of Restricted Stock Units is contingent on Astronics Corp.'s average annual adjusted EBITDA performance for specified periods, meaning the actual number of shares received could be lower than the target if performance metrics are not met.
Future Outlook
The vesting of Restricted Stock Units is tied to Astronics Corp.'s average annual adjusted EBITDA performance for the periods January 1, 2023-December 31, 2025; January 1, 2024-December 31, 2026; and January 1, 2025-December 31, 2027. This indicates a focus on future profitability and operational efficiency as key performance indicators for executive compensation.
Industry Context
This filing reflects standard executive compensation practices within the aerospace and defense industry, where performance-based equity awards like RSUs are common to align executive interests with long-term shareholder value. The planned acquisition through an ESPP is also a common benefit offered to employees.
Comparison to Industry Standards
- The use of performance-based Restricted Stock Units (RSUs) tied to adjusted EBITDA is a common practice in the aerospace and defense sector for executive compensation, similar to companies like Boeing, Raytheon Technologies, or Lockheed Martin, which often link executive incentives to financial metrics such as earnings, cash flow, or return on capital.
- The Employee Stock Purchase Plan (ESPP) is a standard benefit offered by many publicly traded companies across various industries, including technology and manufacturing, to encourage employee ownership and align interests.
Stakeholder Impact
- Shareholders: Increased insider ownership may be viewed as a positive signal of management's belief in the company's future, potentially boosting investor confidence. The performance-based RSUs align executive interests with shareholder value creation.
- Employees: The Employee Stock Purchase Plan provides an opportunity for employees, including executives, to acquire company stock at a potentially favorable price, fostering a sense of ownership.
Next Steps
- Vesting of 10,850 target Restricted Stock Units on February 23, 2026, contingent on 2023-2025 average annual adjusted EBITDA.
- Vesting of 15,900 target Restricted Stock Units on February 22, 2027, contingent on 2024-2026 average annual adjusted EBITDA.
- Vesting of 15,150 target Restricted Stock Units on February 27, 2028, contingent on 2025-2027 average annual adjusted EBITDA.
Key Dates
| Date | Description |
|---|---|
| 12/03/2016 | Date exercisable for options with $27.72 exercise price. |
| 12/14/2017 | Date exercisable for options with $31.76 exercise price. |
| 12/12/2018 | Date exercisable for options with $35.61 exercise price. |
| 12/13/2019 | Date exercisable for options with $31.57 exercise price. |
| 12/09/2020 | Date exercisable for options with $30.04 exercise price. |
| 01/22/2022 | Date exercisable for options with $14.45 exercise price. |
| 12/09/2022 | Date exercisable for options with $11.13 exercise price. |
| 01/01/2023 | Start of performance period for 10,850 target RSUs. |
| 12/16/2023 | Date exercisable for options with $9.74 exercise price. |
| 01/01/2024 | Start of performance period for 15,900 target RSUs. |
| 12/07/2024 | Date exercisable for options with $15.15 exercise price. |
| 01/01/2025 | Start of performance period for 15,150 target RSUs. |
| 08/28/2025 | Date the Form 4 was signed by Power of Attorney for Mark Peabody. |
| 09/30/2025 | Planned date of acquisition of 1,280 shares via Employee Stock Purchase Plan. |
| 12/03/2025 | Expiration date for options with $27.72 exercise price. |
| 12/31/2025 | End of performance period for 10,850 target RSUs. |
| 02/23/2026 | Vesting date for 10,850 target RSUs (vesting between 75% and 115%). |
| 12/14/2026 | Expiration date for options with $31.76 exercise price. |
| 02/22/2027 | Vesting date for 15,900 target RSUs (vesting between 50% and 150%). |
| 12/12/2027 | Expiration date for options with $35.61 exercise price. |
| 02/27/2028 | Vesting date for 15,150 target RSUs (vesting between 50% and 150%). |
| 12/13/2028 | Expiration date for options with $31.57 exercise price. |
| 12/09/2029 | Expiration date for options with $30.04 exercise price. |
| 01/22/2031 | Expiration date for options with $14.45 exercise price. |
| 12/09/2031 | Expiration date for options with $11.13 exercise price. |
| 12/16/2032 | Expiration date for options with $9.74 exercise price. |
| 12/07/2033 | Expiration date for options with $15.15 exercise price. |
Recommendation
holdThis Form 4 primarily reports a routine, pre-planned insider transaction (ESPP acquisition) and details existing equity compensation (options, RSUs). While an executive acquiring shares is generally a positive indicator of confidence, this specific transaction is a future, planned ESPP purchase rather than an open market buy, which typically has less immediate market impact. The RSU vesting conditions are standard for executive incentives. Without additional financial or operational context, this filing alone does not provide sufficient information to warrant a strong buy or sell recommendation, thus a 'hold' is appropriate as it confirms ongoing executive alignment without presenting new, significant catalysts.
Keywords
Astronics Corp, ATRO, Form 4, Insider Transaction, Employee Stock Purchase Plan, ESPP, Stock Options, Restricted Stock Units, Executive Compensation, Mark Peabody, Aerospace
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.